Highland Capital Management, LLC Pfizer Inc Transaction History

Highland Capital Management, LLC

$1.73 Billion
Q3 2024

A detailed history of Highland Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Highland Capital Management, LLC holds 53,942 shares of PFE stock, worth $1.38 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

53,942

Previous 54,241 0.55%

Holding current value

$1.38 Million

Previous $1.52 Million 2.9%

% of portfolio

0.09%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$27.7 - $31.39 $8,282 - $9,385	-299 Reduced 0.55%	53,942 $1.56 Million
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $101,772 - $119,258	-4,029 Reduced 6.91%	54,241 $1.52 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $164,194 - $188,547	-6,342 Reduced 9.82%	58,270 $1.62 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $140,291 - $182,223	-5,369 Reduced 7.67%	64,612 $1.86 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $152,299 - $178,022	-4,746 Reduced 6.35%	69,981 $2.32 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $149,898 - $173,428	-4,150 Reduced 5.26%	74,727 $2.74 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $25,761 - $33,537	-654 Reduced 0.82%	78,877 $3.22 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $3,590 - $4,687	-86 Reduced 0.11%	79,531 $4.08 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $101,041 - $123,346	-2,309 Reduced 2.82%	79,617 $3.48 Million
Q2 2022 Jul 14, 2022	SELL	$46.53 - $55.17 $13,354 - $15,833	-287 Reduced 0.35%	81,926 $4.3 Million
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $188,627 - $233,732	-4,123 Reduced 4.78%	82,213 $4.26 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $27,064 - $40,118	-655 Reduced 0.75%	86,336 $5.1 Million
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $202,333 - $259,915	5,155 Added 6.3%	86,991 $3.74 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $468,876 - $531,158	-13,057 Reduced 13.76%	81,836 $3.21 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $5.91 Million - $6.66 Million	-176,390 Reduced 65.02%	94,893 $3.44 Million
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $704,510 - $895,845	-21,049 Reduced 7.2%	271,283 $9.99 Million
Q3 2020 Oct 16, 2020	SELL	$31.75 - $37.25 $128,079 - $150,266	-4,034 Reduced 1.36%	292,332 $10.7 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $299,543 - $363,390	9,945 Added 3.47%	296,366 $9.69 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $109,768 - $156,835	4,061 Added 1.44%	286,421 $9.35 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $1.49 Million - $1.69 Million	45,332 Added 19.13%	282,360 $11.1 Million
Q3 2019 Nov 20, 2019	SELL	$32.49 - $42.13 $251,115 - $325,622	-7,729 Reduced 3.16%	237,028 $8.52 Million
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $140,893 - $158,191	-3,810 Reduced 1.53%	244,757 $10.6 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $4.54 Million - $4.98 Million	-120,957 Reduced 32.73%	248,567 $10.6 Million
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $9,232 - $10,526	-240 Reduced 0.06%	369,524 $16.1 Million
Q3 2018 Oct 17, 2018	SELL	$34.47 - $41.81 $101,686 - $123,339	-2,950 Reduced 0.79%	369,764 $16.3 Million
Q2 2018 Jul 18, 2018	BUY	$32.98 - $35.16 $16,918 - $18,037	513 Added 0.14%	372,714 $13.5 Million
Q1 2018 Apr 16, 2018	BUY	$31.91 - $37.02 $1.13 Million - $1.31 Million	35,314 Added 10.48%	372,201 $13.2 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $126,886 - $134,631	-3,815 Reduced 1.12%	336,887 $12.2 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $10.6 Million - $11.6 Million	340,702	340,702 $12.2 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Account

Highland Capital Management, LLC Pfizer Inc Transaction History